Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Cannabis
  • Markets
  • Movers

Small Pharma, Cybin Among Top Psychedelic Movers Of Today

By Benzinga Insights
September 1, 5:39 PM
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS:

ALID

Read More
2 minute read
  • Cannabis
  • Contracts
  • Global
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics

By Lara Goldstein
September 1, 3:56 PM
Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog.

OPTHF

Read More
3 minute read
  • Cannabis
  • Events
  • Exclusives
  • Markets
  • Media
  • News
  • Penny Stocks

EXCLUSIVE: Outstanding Cannabis Podcasts, Meet The Producers & Guests At Benzinga Cannabis Capital Conference

By Maureen Meehan
September 1, 2:30 PM
A stroll through Spotify (NYSE: SPOT) and Apple (NASDAQ: AAPL) iTunes reveals that there are over 2000 cannabis-related podcasts. 

AAPL

Read More
2 minute read
  • Cannabis
  • Global
  • Management
  • Markets
  • Mid Cap
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psychedelics Funding At Its Best: $1.5M Destined To Psilocin Clinical Trials In Australia

By Lara Goldstein
September 1, 2:20 PM
Psychedelics biopharma company Lobe Sciences Ltd.

ATAI

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Earnings
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Reiteration
  • Small Cap
  • Trading Ideas

Jushi’s Earnings Power Grows But This Analyst Remains Sidelined, Here’s Why

By Jelena Martinovic
September 1, 11:36 AM
Cannabis company Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) reported a 52.4% year-over-year increase in second-quarter revenue to $72.8 million, attributing

CSE:JUSH

Read More
2 minute read
  • Cannabis
  • Markets
  • News

Isracann’s Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative Pharmacy

By Vuk Zdinjak
September 1, 10:42 AM
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, has signed a distribution agreement for Praesidio Health products with

CSE:IPOT

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Medical Cannabis Company Khiron, Launching New Products In Europe

By Vuk Zdinjak
September 1, 10:14 AM
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC), is launching its new medical product portfolio in Europe.

KHRNF

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Markets
  • News
  • Price Target

Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Lowers Price Target to $2.25

By Benzinga Newsdesk
September 1, 5:23 AM
Cantor Fitzgerald analyst Pablo Zuanic maintains Jushi Holdings (OTC:JUSHF) with a Neutral and lowers the price target from $2.5 to $2.25.

JUSHF

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In Cannabis Paradise?

By Joana Scopel
August 31, 7:15 PM
Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY), which closed its acquisition of rival Aphria, Inc. (APHA) in 2021, could face a lawsuit brought by former Aphria shareholders.

TLRY

Read More
1 minute read
  • Cannabis
  • Markets
  • Movers

Cannabis Stock Movers For August 31, 2022

By Benzinga Insights
August 31, 5:42 PM
GAINERS: Cansortium (OTC:CNTMF) shares closed up 12.50% at $0.18

ACB

Posts pagination

Previous 1 … 402 403 404 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service